Cargando…
Shifting emphasis from pharmacogenomics to theragnostics
What will be the role of theragnostic patents in upstream and downstream biomarker research?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096916/ https://www.ncbi.nlm.nih.gov/pubmed/16900136 http://dx.doi.org/10.1038/nbt0806-942 |
| _version_ | 1783510926966652928 |
|---|---|
| author | Ozdemir, Vural Williams-Jones, Bryn Glatt, Stephen J Tsuang, Ming T Lohr, James B Reist, Christopher |
| author_facet | Ozdemir, Vural Williams-Jones, Bryn Glatt, Stephen J Tsuang, Ming T Lohr, James B Reist, Christopher |
| author_sort | Ozdemir, Vural |
| collection | PubMed |
| description | What will be the role of theragnostic patents in upstream and downstream biomarker research? |
| format | Online Article Text |
| id | pubmed-7096916 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70969162020-03-26 Shifting emphasis from pharmacogenomics to theragnostics Ozdemir, Vural Williams-Jones, Bryn Glatt, Stephen J Tsuang, Ming T Lohr, James B Reist, Christopher Nat Biotechnol Article What will be the role of theragnostic patents in upstream and downstream biomarker research? Nature Publishing Group US 2006 /pmc/articles/PMC7096916/ /pubmed/16900136 http://dx.doi.org/10.1038/nbt0806-942 Text en © Nature Publishing Group 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Article Ozdemir, Vural Williams-Jones, Bryn Glatt, Stephen J Tsuang, Ming T Lohr, James B Reist, Christopher Shifting emphasis from pharmacogenomics to theragnostics |
| title | Shifting emphasis from pharmacogenomics to theragnostics |
| title_full | Shifting emphasis from pharmacogenomics to theragnostics |
| title_fullStr | Shifting emphasis from pharmacogenomics to theragnostics |
| title_full_unstemmed | Shifting emphasis from pharmacogenomics to theragnostics |
| title_short | Shifting emphasis from pharmacogenomics to theragnostics |
| title_sort | shifting emphasis from pharmacogenomics to theragnostics |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096916/ https://www.ncbi.nlm.nih.gov/pubmed/16900136 http://dx.doi.org/10.1038/nbt0806-942 |
| work_keys_str_mv | AT ozdemirvural shiftingemphasisfrompharmacogenomicstotheragnostics AT williamsjonesbryn shiftingemphasisfrompharmacogenomicstotheragnostics AT glattstephenj shiftingemphasisfrompharmacogenomicstotheragnostics AT tsuangmingt shiftingemphasisfrompharmacogenomicstotheragnostics AT lohrjamesb shiftingemphasisfrompharmacogenomicstotheragnostics AT reistchristopher shiftingemphasisfrompharmacogenomicstotheragnostics |